Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia

Michiyo Kuyama, Gen Nakanishi, Jirô Arata, Keiji Iwatsuki, Wataru Fujimoto

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Double-stranded RNA-activated protein kinase (PKR) is a interferon-induced protein initially known for its inhibitory effects on cellular and viral protein synthesis. In recent studies, PKR has been shown to be an important participant in a broad array of cellular processes, including signal transduction, differentiation, apoptosis, cell growth, and tumorigenesis. The expression of PKR in normal human keratinocytes (NHEK) was examined, and its expression in several skin lesions was compared immunohistochemically with that of proliferating cell nuclear antigen (PCNA). Expression of PKR mRNA was detected in NHEK without IFNγ treatment; the level of PKR mRNA increased with IFNγ treatment for two hours. Immunoblot analysis revealed that the monoclonal anti-PKR antibody reacted specifically with a 68kDa PKR protein in extracts from NHEK. Immunohistochemistry revealed that PKR protein was expressed in normal epidermis and mucosa. PKR expression was not restricted only to suprabasal cells but was also observed in basal cells positive for PCNA. In psoriatic plaques, PKR expression was lower in basal and parabasal keratinocytes and comparable in suprabasal keratinocytes to the levels in normal skin. PKR was partially detected in atypical cells in non-invasive keratinocytic neoplasia but was completely absent from undifferentiated tumor cells of squamous cell carcinoma. The present study demonstrated that PKR protein is constitutively expressed in epidermal and epithelial keratinocytes of normal skin and mucosa and indicated that a loss of PKR is not associated with the malignant transformation itself but with the increased cell proliferative activity and the altered differentiation of keratinocytes.

Original languageEnglish
Pages (from-to)579-589
Number of pages11
JournalJournal of Dermatology
Volume30
Issue number8
Publication statusPublished - Aug 1 2003
Externally publishedYes

Fingerprint

eIF-2 Kinase
Double-Stranded RNA
Keratinocytes
Proliferating Cell Nuclear Antigen
Neoplasms
Skin
Mucous Membrane
Proteins
Messenger RNA
Viral Proteins
Epidermis
Interferons
Cell Differentiation
Anti-Idiotypic Antibodies
Squamous Cell Carcinoma
Signal Transduction
Carcinogenesis
Immunohistochemistry
Monoclonal Antibodies
Apoptosis

Keywords

  • Epidermis
  • IFNγ
  • Keratinocyte
  • PCNA
  • PKR

ASJC Scopus subject areas

  • Dermatology

Cite this

Kuyama, M., Nakanishi, G., Arata, J., Iwatsuki, K., & Fujimoto, W. (2003). Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia. Journal of Dermatology, 30(8), 579-589.

Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia. / Kuyama, Michiyo; Nakanishi, Gen; Arata, Jirô; Iwatsuki, Keiji; Fujimoto, Wataru.

In: Journal of Dermatology, Vol. 30, No. 8, 01.08.2003, p. 579-589.

Research output: Contribution to journalArticle

Kuyama, M, Nakanishi, G, Arata, J, Iwatsuki, K & Fujimoto, W 2003, 'Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia', Journal of Dermatology, vol. 30, no. 8, pp. 579-589.
Kuyama M, Nakanishi G, Arata J, Iwatsuki K, Fujimoto W. Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia. Journal of Dermatology. 2003 Aug 1;30(8):579-589.
Kuyama, Michiyo ; Nakanishi, Gen ; Arata, Jirô ; Iwatsuki, Keiji ; Fujimoto, Wataru. / Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia. In: Journal of Dermatology. 2003 ; Vol. 30, No. 8. pp. 579-589.
@article{36b497aefc1c48bb94ec864559f71b07,
title = "Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia",
abstract = "Double-stranded RNA-activated protein kinase (PKR) is a interferon-induced protein initially known for its inhibitory effects on cellular and viral protein synthesis. In recent studies, PKR has been shown to be an important participant in a broad array of cellular processes, including signal transduction, differentiation, apoptosis, cell growth, and tumorigenesis. The expression of PKR in normal human keratinocytes (NHEK) was examined, and its expression in several skin lesions was compared immunohistochemically with that of proliferating cell nuclear antigen (PCNA). Expression of PKR mRNA was detected in NHEK without IFNγ treatment; the level of PKR mRNA increased with IFNγ treatment for two hours. Immunoblot analysis revealed that the monoclonal anti-PKR antibody reacted specifically with a 68kDa PKR protein in extracts from NHEK. Immunohistochemistry revealed that PKR protein was expressed in normal epidermis and mucosa. PKR expression was not restricted only to suprabasal cells but was also observed in basal cells positive for PCNA. In psoriatic plaques, PKR expression was lower in basal and parabasal keratinocytes and comparable in suprabasal keratinocytes to the levels in normal skin. PKR was partially detected in atypical cells in non-invasive keratinocytic neoplasia but was completely absent from undifferentiated tumor cells of squamous cell carcinoma. The present study demonstrated that PKR protein is constitutively expressed in epidermal and epithelial keratinocytes of normal skin and mucosa and indicated that a loss of PKR is not associated with the malignant transformation itself but with the increased cell proliferative activity and the altered differentiation of keratinocytes.",
keywords = "Epidermis, IFNγ, Keratinocyte, PCNA, PKR",
author = "Michiyo Kuyama and Gen Nakanishi and Jir{\^o} Arata and Keiji Iwatsuki and Wataru Fujimoto",
year = "2003",
month = "8",
day = "1",
language = "English",
volume = "30",
pages = "579--589",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia

AU - Kuyama, Michiyo

AU - Nakanishi, Gen

AU - Arata, Jirô

AU - Iwatsuki, Keiji

AU - Fujimoto, Wataru

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Double-stranded RNA-activated protein kinase (PKR) is a interferon-induced protein initially known for its inhibitory effects on cellular and viral protein synthesis. In recent studies, PKR has been shown to be an important participant in a broad array of cellular processes, including signal transduction, differentiation, apoptosis, cell growth, and tumorigenesis. The expression of PKR in normal human keratinocytes (NHEK) was examined, and its expression in several skin lesions was compared immunohistochemically with that of proliferating cell nuclear antigen (PCNA). Expression of PKR mRNA was detected in NHEK without IFNγ treatment; the level of PKR mRNA increased with IFNγ treatment for two hours. Immunoblot analysis revealed that the monoclonal anti-PKR antibody reacted specifically with a 68kDa PKR protein in extracts from NHEK. Immunohistochemistry revealed that PKR protein was expressed in normal epidermis and mucosa. PKR expression was not restricted only to suprabasal cells but was also observed in basal cells positive for PCNA. In psoriatic plaques, PKR expression was lower in basal and parabasal keratinocytes and comparable in suprabasal keratinocytes to the levels in normal skin. PKR was partially detected in atypical cells in non-invasive keratinocytic neoplasia but was completely absent from undifferentiated tumor cells of squamous cell carcinoma. The present study demonstrated that PKR protein is constitutively expressed in epidermal and epithelial keratinocytes of normal skin and mucosa and indicated that a loss of PKR is not associated with the malignant transformation itself but with the increased cell proliferative activity and the altered differentiation of keratinocytes.

AB - Double-stranded RNA-activated protein kinase (PKR) is a interferon-induced protein initially known for its inhibitory effects on cellular and viral protein synthesis. In recent studies, PKR has been shown to be an important participant in a broad array of cellular processes, including signal transduction, differentiation, apoptosis, cell growth, and tumorigenesis. The expression of PKR in normal human keratinocytes (NHEK) was examined, and its expression in several skin lesions was compared immunohistochemically with that of proliferating cell nuclear antigen (PCNA). Expression of PKR mRNA was detected in NHEK without IFNγ treatment; the level of PKR mRNA increased with IFNγ treatment for two hours. Immunoblot analysis revealed that the monoclonal anti-PKR antibody reacted specifically with a 68kDa PKR protein in extracts from NHEK. Immunohistochemistry revealed that PKR protein was expressed in normal epidermis and mucosa. PKR expression was not restricted only to suprabasal cells but was also observed in basal cells positive for PCNA. In psoriatic plaques, PKR expression was lower in basal and parabasal keratinocytes and comparable in suprabasal keratinocytes to the levels in normal skin. PKR was partially detected in atypical cells in non-invasive keratinocytic neoplasia but was completely absent from undifferentiated tumor cells of squamous cell carcinoma. The present study demonstrated that PKR protein is constitutively expressed in epidermal and epithelial keratinocytes of normal skin and mucosa and indicated that a loss of PKR is not associated with the malignant transformation itself but with the increased cell proliferative activity and the altered differentiation of keratinocytes.

KW - Epidermis

KW - IFNγ

KW - Keratinocyte

KW - PCNA

KW - PKR

UR - http://www.scopus.com/inward/record.url?scp=0042820277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042820277&partnerID=8YFLogxK

M3 - Article

C2 - 12928526

AN - SCOPUS:0042820277

VL - 30

SP - 579

EP - 589

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 8

ER -